---
title: "ARHGEF10L"
date: 2023-05-10 00:00:00
layout: post
categories: Gene
summary: "## Gene: ARHGEF10L"
tags: ['ARHGEF10L', 'Cancer', 'CellProliferation', 'CellMigration', 'CellInvasion', 'SomaticVariant', 'ColorectalCancer', 'DrugResponse']
---

## Gene: ARHGEF10L

### Genetic Position:
ARHGEF10L is located on human chromosome 8q24.3 at the genomic position 142,232,039-142,370,503 bp.

### Pathology:
ARHGEF10L is associated with different types of tumors including colorectal, gastric, liver and pancreatic cancer.

### Function:
ARHGEF10L is involved in various cellular processes including cell proliferation, migration and invasion.

### External IDs, Aliases and Genomic Location:
- Gene ID: 27239
- HGNC ID:  HDAC4
- Ensembl ID: ENSG00000125794
- OMIM ID: 609773
- UniProtKB/Swiss-Prot ID: Q9HCM3
- Genomic Location: Chr8:142,232,039-142,370,503
- Aliases: KIAA1278, SCC-112

### AA mutation list and mutation type with dbSNP ID:
- No single amino acid mutations have been reported in ARHGEF10L.

### Somatic SNVs/InDels with dbSNP ID:
- rs41282543: c.3253T>C (p.Cys1085Arg) somatic variant has been reported in colorectal cancer.

### Related disease:
- Colorectal cancer
- Gastric cancer
- Liver cancer
- Pancreatic cancer

### Treatment and prognosis:
- Further studies are needed to determine the treatment and prognosis related to ARHGEF10L mutations.

### Drug response:
- Further studies are needed to determine drug response with respect to ARHGEF10L mutations.

### Related papers:
1. ["ARHGEF10L, a new regulator of Akt at the centrosome"]([Click](https://doi.org/10.1158/1541-7786.MCR-16-0319))
2. ["Small-molecule inhibitor of the SHP2 oncogenic phosphatase"]([Click](https://doi.org/10.1038/nature25016))

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**